Gray Market Peptides: So Much Hype, So Little Data FDA Peptide Update: Category 2 Removals Explained FDA takes first step in possible reversal of ban on some peptides The Washington Post We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University